Skip to main content

Coronavirus Infections

MERS-CoV: diagnostic testing.

UK Health Security Agency (UKHSA); 2026.

Published on 19/5/2026
MERS-CoV: diagnosis and management of cases and contacts.

UK Health Security Agency (UKHSA); 2026.

Published on 19/5/2026
MERS-CoV: risk assessment.

UK Health Security Agency (UKHSA); 2026.

Published on 19/5/2026
Evaluating the use of the first WHO International Standard for anti-SARS-CoV-2 immunoglobulin to harmonise the readouts between commercial SARS-CoV-2 binding antibody tests: the HARMONY multicentre calibration study.

Semper A. The Lancet Microbe 2026;:https://doi.org/10.1016/j.lanmic.2025.101329.

Published on 21/5/2026
Three-year follow-up of the COVAXID trial: real-world assessment of SARS-CoV-2 mRNA vaccine immunogenicity in immunocompromised individuals highlights increasing roles of hybrid and passive immunity.

Chen P. eBioMedicine 2026;:https://doi.org/10.1016/j.ebiom.2026.106279.

Published on 21/5/2026
Health, economic, and equity impact of a COVID-19 mobile vaccine clinic program in US: a cost-effectiveness analysis.

Duong KNC. The Lancet Regional Health – Americas 2026;:https://doi.org/10.1016/j.lana.2026.101488.

Published on 21/5/2026
Time to endemicity of SARS-CoV-2 in a sentinel cohort in the Netherlands: findings from a prospective observational study.

Jongen VW. The Lancet Microbe 2026;:https://doi.org/10.1016/j.lanmic.2025.101314.

Published on 21/5/2026
Early transcriptional responses following Ad26.COV2.S vaccination in individuals with prior SARS-CoV-2 infection.

Rezelj VV. eBioMedicine 2026;:https://doi.org/10.1016/j.ebiom.2026.106270.

Published on 21/5/2026
Convalescent plasma for people with COVID-19.

Iannizzi C. Cochrane Database of Systematic Reviews 2026;5:CD013600.

Published on 14/5/2026
Addressing the Costs and Care for Long COVID : The Long Shadow of the Pandemic.

Organisation for Economic Co-operation and Development (OECD); 2026.

Published on 12/5/2026

1
2
3
4
5
...